Ricki Pollycove
Gynecology · San Francisco, CANPI 1013097013
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $26,352 of the $35,535 with a category attached, or 74.2%. Astellas Pharma US Inc accounts for 63.7% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2023 at $18,994 and has fallen 61.1% since, to $7,388 in 2025. Among gynecology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 124 payments — averaging $286.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$23K
- Pfizer$5K
- Ascend Therapeutics US, LLC$4K
- Bayer$2K
- Astellas Pharma Global Development$441
- Mayne Pharma Commercial LLC$349
- plus $1K from 14 others
What the payments were for
- Consulting fees$1,5004%
- Speaking & faculty fees$26,35274%
- Travel & lodging$3,66410%
- Food & beverage$3,65210%
- Education$3581%
- Gifts$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 30 | $22,635 |
| Pfizer | 6 | $4,820 |
| Ascend Therapeutics US, LLC | 26 | $4,430 |
| Bayer | 3 | $1,616 |
| Astellas Pharma Global Development | 4 | $441 |
| Mayne Pharma Commercial LLC | 24 | $349 |
| AMAG Pharmaceuticals, Inc. | 3 | $259 |
| Therapeuticsmd, Inc. | 4 | $191 |
| AbbVie | 7 | $179 |
| Intuitive Surgical | 1 | $132 |
| Novo Nordisk | 1 | $130 |
| Lilly USA, LLC | 3 | $73 |
| IBSA Pharma Inc. | 3 | $59 |
| Myovant Sciences Inc. | 2 | $47 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Exact Sciences | 1 | $31 |
| Integra Lifesciences Corporation | 1 | $27 |
| Avion Pharmaceuticals | 1 | $27 |
| Exeltis, USA Inc. | 1 | $24 |
| Millicent US Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$35,535 in reported general payments places this provider in the 95th percentile of 247 gynecology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FemringEstradiol Acetate | 90 | $68,149 |
| Estradiol (Twice Weekly)Estradiol | 372 | $35,584 |
| MinivelleEstradiol | 37 | $15,282 |
| Estradiol | 123 | $13,464 |
| ImvexxyEstradiol | 31 | $9,968 |
| ProgesteroneProgesterone, Micronized | 181 | $7,368 |
| PremarinEstrogens, Conjugated | 16 | $7,102 |
| DottiEstradiol | 62 | $6,849 |
| EstringEstradiol | 12 | $6,209 |
| LyllanaEstradiol | 58 | $5,090 |
| Vivelle-DotEstradiol | 23 | $4,735 |
| ValacyclovirValacyclovir Hcl | 33 | $2,649 |
| YuvafemEstradiol | 14 | $2,101 |
| SynthroidLevothyroxine Sodium | 23 | $1,729 |
| Zolpidem Tartrate | 14 | $1,032 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Millicent US IncFemring | $19 | $68,14990 claims |
| PfizerPremarin, Estring | $4,820 | $13,31128 claims |
| Therapeuticsmd, Inc.Imvexxy | $191 | $9,96831 claims |
| AbbVieSynthroid, Armour Thyroid | $179 | $2,74135 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 247 gynecology providers in California.
Other gynecology in San Francisco
- Bruce LeeMonterey$2.8M
- Barbara Levyla Jolla$719K
- Samar NahasRiverside$132K
- Aarathi CholkeriEl Segundo$128K
- Kelly WrightLos Angeles$119K
- Naphthali AlinsodLaguna Beach$108K
- Albertine OmaniOakland$70K
- Matthew SiedhoffBeverly Hills$67K
- Justin DiedrichAgoura Hills$46K
- Thomas CunninghamMonterey$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.